Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Abroad (travel likely)RecruitingPHASE2

Conditions

Bile Duct Cancer · Cholangiocarcinoma · Cholangiocarcinoma Non-resectable · Cholangiocarcinoma Metastatic · Metastatic Intrahepatic Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Study coordinator (Andrea Bullock, MD, MPH) · abullock@bidmc.harvard.edu · 617-667-2100
Contact: Principal Investigator (Andrea Bullock, MD, MPH)

Study leads

Andrea Bullock, MD, MPH
Principal Investigator
Beth Israel Deaconess Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma

Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Naples, Italy · Naples, Italy

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Pancreatic Adenocarcinoma · Cholangiocarcinoma · Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Chengdu, China

Targeted Navigation in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma · Cholangiocarcinoma · Hepatobiliary Cancer

Abroad (travel likely)Recruiting

Miami, United States